LUO Lisha 1 # , LUAN Hanghang 2 , ZHENG Hang 3 , WANG Yongbo 1 , ZHU Cong 1,3 , LI Binghui 1,3 , ZI Hao 1,3 , ZENG Xiantao 1
  • 1. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;
  • 2. Department of Forensic Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;
  • 3. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;
ZENG Xiantao, Email: zengxiantao1128@163.com
Prostate cancer; Bladder cancer; Kidney cancer; Smoking; Disease burden
10.7507/1672-2531.202201059
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective To analyze the disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019. Methods Based on the global burden of disease study 2019, the current situation of the disease burden of prostate, bladder and kidney cancers attributable to smoking was analyzed by using the population attributable fraction (PAF), deaths and disability-adjusted life years (DALYs). Furthermore, the annual percent change (APC) and the average annual percent change (AAPC) were calculated by joinpoint regression analysis to describe the long-term trends of the smoking-attributable burden of these three cancers from 1990 to 2019. Results There were an estimated 18 800 cases of deaths and 393 106 person-years of DALYs for bladder cancer caused by smoking in 2019. The age-standardized mortality and DALY rate decreased by 0.41% and 0.39% per year from 1990 to 2019, respectively. For prostate cancer, smoking was estimated to have caused 5 016 cases of deaths and 98 276 person-years of DALYs in 2019. The age-standardized mortality and DALY rate decreased by 0.28% and 0.25% per year from 1990 to 2019, respectively. For kidney cancer, the deaths and DALYs attributable to smoking were 4 935 cases and 120 620 person-years, respectively. The standardized mortality and DALY rates increased by 3.03% and 2.98% per year from 1990 to 2019. Additionally, males suffered from a higher disease burden of these three cancers attributable to smoking than females. The elderly population had a higher smoking-attributable disease burden than the younger population. Conclusion The situation of the disease burden of bladder, prostate and kidney cancers attributable to smoking is still serious in China, which has substantial disparities in different groups. Specifically, males and the elderly are the high-risk groups for the smoking-attributable burden. Among the three cancers, bladder cancer has the highest burden and kidney cancer has the largest burden increase during 1990-2019.

Citation： LUO Lisha, LUAN Hanghang, ZHENG Hang, WANG Yongbo, ZHU Cong, LI Binghui, ZI Hao, ZENG Xiantao. An analysis of disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019. Chinese Journal of Evidence-Based Medicine, 2022, 22(5): 530-536. doi: 10.7507/1672-2531.202201059 Copy

  • Previous Article

    Analysis of disease burden of skin malignant melanoma in China

  • Next Article

    Diagnostic value of miRNAs for Alzheimer’s disease: a meta-analysis